6661
威健生技
0.00 (0.00%)16.155成交張數–本益比1.38股價淨值比0.00%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | -0.07 | – | -0.06 | -0.02 | -1.6% | -0.63% | -0.59% |
| 2026Q1 | -0.27 | – | -0.01 | -0.06 | -7.5% | -2.26% | -0.14% |
| 2025Q4 | -0.02 | – | 0.06 | -0.01 | -0.7% | -0.23% | 0.47% |
| 2025Q3 | 0.30 | -9.1% | 0.07 | 0.07 | 6.4% | 2.45% | 0.57% |
| 2025Q2 | -0.02 | – | 0.10 | -0.00 | -0.5% | -0.16% | 0.81% |
| 2025Q1 | -0.20 | – | 0.09 | -0.05 | -5.9% | -1.60% | 0.78% |
| 2024Q4 | -0.01 | – | 0.05 | -0.00 | -0.4% | -0.12% | 0.38% |
| 2024Q3 | 0.33 | – | -0.05 | 0.08 | 8.5% | 2.66% | -0.44% |
| 2024Q2 | -0.03 | -112.0% | -0.42 | -0.01 | -0.7% | -0.19% | -3.35% |
| 2024Q1 | -0.24 | – | -0.14 | -0.06 | -8.3% | -1.97% | -1.18% |
| 2023Q4 | -0.11 | – | -0.11 | -0.03 | -3.7% | -0.93% | -0.89% |
| 2023Q3 | -0.04 | -120.0% | -0.11 | -0.01 | -1.1% | -0.29% | -0.81% |
| 2023Q2 | 0.25 | -53.7% | 0.13 | 0.06 | 7.6% | 1.97% | 1.03% |
| 2023Q1 | -0.21 | – | 0.42 | -0.05 | -10.0% | -1.64% | 3.33% |
| 2022Q4 | -0.11 | -119.0% | 0.41 | -0.03 | -3.5% | -0.83% | 3.11% |
| 2022Q3 | 0.20 | – | 1.10 | 0.05 | 6.5% | 1.53% | 8.43% |
| 2022Q2 | 0.54 | 107.7% | 0.90 | 0.12 | 11.8% | 4.20% | 6.95% |
| 2022Q1 | -0.22 | – | 0.62 | -0.05 | -7.1% | -1.69% | 4.65% |
| 2021Q4 | 0.58 | – | 0.59 | 0.14 | 12.8% | 4.47% | – |
| 2021Q3 | 0.00 | – | – | -0.00 | -0.1% | -0.03% | – |
| 2021Q2 | 0.26 | – | – | 0.06 | 7.6% | 1.88% | – |
| 2021Q1 | -0.25 | – | – | -0.06 | -11.5% | – | – |